Mon, July 31, 2023

Raghuram Selvaraju Reiterated (AQST) at Strong Buy and Held Target at $5 on, Jul 31st, 2023

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aquestive Therapeutics, Inc." (AQST) at Strong Buy and Held Target at $5 on, Jul 31st, 2023.

Raghuram has made no other calls on AQST in the last 4 months.



There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Jason Butler of "JMP Securities" Reiterated at Buy and Held Target at $8 on, Friday, June 30th, 2023